ArticleArthritis research & therapy2013

In vitro suppression of immune responses using monocyte-derived tolerogenic dendritic cells from patients with primary Sjögren's syndrome.

Roman Volchenkov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.